Last updated: November 23, 2023
Sponsor: Semmelweis University
Overall Status: Active - Recruiting
Phase
4
Condition
N/ATreatment
Full-thickness group
Split-thickness group
Clinical Study ID
NCT05538715
Augmentation-Semmelweis-Perio
Ages 18-90 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- at least one edentulous maxillary/mandibulary premolar or molar site with horizontalbone loss
- full- mouth plaque and bleeding scores (FMPS and FMBS) <20%
- good patient compliance (including willingness to participate in the follow-upprocedures) signed informed consent-
Exclusion
Exclusion Criteria:
- Active infectious diseases (HBV, HCV, HIV, TB, SARS CoV-2, etc.)
- Current chemotherapy or radiotherapy
- Radiation treatment of the former head and neck region (not older than 2 years)
- Untreated insulin-dependent diabetes mellitus
- Clinically significant osteoporosis or other systemic disease affecting bonemetabolism
- Clinically significant circulatory disorders such as decompensated cardiac failure
- Haemodynamically significant heart failure or myocardial infarction within the last 3months
- Clinically significant coagulation disorder
- Current or previous systemic corticosteroid therapy (not older than 2 months)
- Current or previous systemic bisphosphonate therapy
- Pregnant or breastfeeding mothers
- Smoking
- Drug addiction, alcoholism
Study Design
Total Participants: 44
Treatment Group(s): 2
Primary Treatment: Full-thickness group
Phase: 4
Study Start date:
November 08, 2019
Estimated Completion Date:
September 30, 2024
Study Description
Connect with a study center
Semmelweis University Department of Periodontology
Budapest, 1088
HungaryActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.